The Lymphoma Coalition’s Natacha Bolaños outlines the fundamentals of the lymphoma patient experience today, the growing number of innovative new treatment options available, and the issues surrounding their integration as earlier lines of treatment.
CAR-T is not necessarily the best treatment option for everyone. There could be other second-best options for a certain group of patients. Our point of view as patient advocates is that patients should be given an exhaustive explanation about the treatment they will undergo, and side effects should not be overlooked
